If that were true, it would mean India has found one of the holy grails of reproductive medicine — overcoming the biological and regulatory challenges that have thwarted past attempts to bring a new male birth control to market. (For more on those, and other promising male birth control options, see here.)
如果这都是真的,那就意味着印度已经发现了生殖医学一直在寻找的东西,那就是克服生物和监管方面的困难,就因为这些困难,所以一直不能将新的男性节育方法推向市场。(想要了解更多信息和其他可能的男性避孕方法,请看这里。)
The product is a nonsurgical vasectomy called RISUG, which stands for “reversible inhibition of sperm under guidance,” and it’s effectively an injection behind men’s penises. If that sounds like something no man would ever agree to, let me explain.
这个被称为RISUG的产品是非手术输精管结扎术,RISUG代表的是“在引导下对精子进行可逆抑制”,实际上是在男人阴茎后注射。如果这听起来男人不会接受的话,那我解释一下。
With RISUG, doctors inject a polymer gel into the vas deferens, the tube that transports mature sperm to the urethra during ejaculation, under local anesthesia. The procedure is intended to block sperm, and therefore, the chances that a man impregnates a woman, with effects that can last for 13 years, Sharma told the Hindustan Times.
【全球首个男性避孕药或将推出】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15